New York University Cancer Cen
160 East 34th Street
New York, New York 10016

Use our guide to learn which trials are right for you!

We've found
2 trials
at this facility
Lymphoma Clinical Trial
A Study of Polatuzumab Vedotin (DCDS4501A) in Combination With Rituximab or Obinutuzumab Plus Bendamustine in Participants With Relapsed or Refractory Follicular or Diffuse Large B-Cell Lymphoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
New York University Cancer Cen
mi
from
New York, NY
Click here to add this to my saved trials
Diffuse Large B-Cell Lymphoma Clinical Trial
A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Diffuse Large B-Cell Lymphoma
Status: Enrolling, Phase III
Updated: 12/31/1969
New York University Cancer Cen
mi
from
New York, NY
Click here to add this to my saved trials